2006 annual financial data
Regeneron Pharmaceuticals 2006 Operating margin
Direct answer
Operating margin was -169.13%.
Operating income was -107,307,000 USD and net income was -102,337,000 USD.
Operating cash flow was 23,075,000 USD.
Get free Regeneron Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 63,447,000 USD
- Operating income
- -107,307,000 USD
- Net income
- -102,337,000 USD
- Operating cash flow
- 23,075,000 USD